跳至主要内容
临床试验/IRCT2016080429191N1
IRCT2016080429191N1已完成1 期

The frst phase of clinical trial of of carvacrol to evaluate the safety and tolerability of the substance in humans

Vice chancellor for research, Mashhad University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 60 years(—)
性别
All

入选标准

  • Main conditions of entry to study: Physical and mental health; no history of serious illness; the age limit from 20 to 60 years; write informed consent
  • Main condition of exclusion from study: cardiovascular diseases; brain and vascular disease; malignancy; chronic inflammatory diseases; autoimmune disorders; psychiatric disorders; metabolic diseases; endocrine disorders; other underlying diseases other than those mentioned; one tends to withdraw from the study; drug intolerance; drug use by participants during the study

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Mashhad University of Medical Sciences

相似试验